Record Number of Abstracts Submitted for ACDM19
Date: October 1, 2018
The deadline for Abstracts for ACDM19 passed on the 30th September and the Association for Clinical Data Management (ACDM) are delighted to announce a three fold increase in the number of Abstracts submitted. Abstracts have been submitted from a wide range of organisations and from across the World. Over the coming weeks the Organising Group will review all abstracts and start to collate the final Programme for ACDM19.
ACDM19 will run from the 11th to 12th March 2019 in Amsterdam. Delegate, Exhibition and Sponsorship Bookings are open.
For full details on the Annual Conference please visit: https://www.acdmconference.org
Explore More News

New MHRA Guidance
The MHRA have published new guidance on ‘Software and Artificial Intelligence (AI) as a . . .
Read More

FDA Guidance for Industry
The FDA has issued a final guidance to provide information on risk-based approaches to . . .
Read More

Guideline on computerised systems and electronic data in clinical trials
The European Medicines Agency (EMA) have published the new guidelines on computerised . . .
Read More

Welcome IROS – Insights Research Organization & Solutions as a new corporate member
The ACDM: Association for Clinical Data Management is delighted to welcome IROS – Insights . . .
Read More

Recommendation paper on decentralised elements in clinical trials
Following their meeting on 4 Oct, the EMA/HTAs and EC have published a recommendation . . .
Read More

Welcome George Clinical as a new corporate member
The ACDM: Association for Clinical Data Management is delighted to welcome George Clinical . . .
Read More

Welcome Clinion as a new corporate member
The ACDM: Association for Clinical Data Management is delighted to welcome Clinion as a . . .
Read More

Welcome ClinoSol Research as a new corporate member
The ACDM: Association for Clinical Data Management is delighted to welcome ClinoSol . . .
Read More

CTU DMEG Update
The CTU DMEG has been actively discussing common problems that data managers face in . . .
Read More

ICH E8 (R1) General Considerations for Clinical Studies Impact on Data Management
The ACDM Regulatory Considerations have reviewed the Revision 1 to the ICH E8 Guidelines . . .
Read More

ACDM Comments on “Digital Health Technologies for Remote Data Acquisition in Clinical Investigations; Draft Guidance for Industry, Investigators, and Other Stakeholders; Availability”
https://acdmglobal.org/wp-content/uploads/2022/04/ACDM_FDA_DHT.pdf
Read More

Have your say – MHRA’s public consultation on proposals for legislative changes for clinical trials
Dear Colleague,
We have just launched our 8-week public consultation on proposals for . . .
Read More